Close Menu

NEW YORK(GenomeWeb) – Roche today said it has extended the expiration of its tender offer for common shares of Foundation Medicine to midnight EST at the end of the day April 6. 

The tender offer for 15,604,288 shares of Foundation's stock at $50 per share is part of a $1.2 billion stake that Roche plans to take in the Cambridge, Mass.-based cancer molecular diagnostics firm. All other terms and conditions of the tender offer remain the same.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

Wired reports that researchers have shown they could reprogram a DNA-based computer.

Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.

In Science this week: whole-genome sequencing of single sperm cells, and more.